BOOK-CHAPTER
Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer
Hans J. HammersEmmanuel S. Antonarakis
Year: 2014 Current clinical urology Pages: 249-252 Publisher: Springer Nature
Keywords:
PI3K/AKT/mTOR pathway Temsirolimus Everolimus PTEN Prostate cancer Protein kinase B Medicine Cancer research Cancer Pharmacology Signal transduction Discovery and development of mTOR inhibitors Internal medicine Biology Cell biology
Metrics
1
Cited By
0.00
FWCI (Field Weighted Citation Impact)
19
Refs
0.07
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Citation History
Topics
PI3K/AKT/mTOR signaling in cancer
Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology
Prostate Cancer Treatment and Research
Health Sciences → Medicine → Pulmonary and Respiratory Medicine
Multiple Myeloma Research and Treatments
Health Sciences → Medicine → Hematology
Related Documents
BOOK-CHAPTER
Targeting PI3K/AKT/mTOR Pathway
Carmen CriscitielloGiuseppe Curigliano
Breast Cancer Year: 2017 Pages: 787-793
JOURNAL ARTICLE
Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
Fernanda MusaRobert J. Schneider
Journal: Translational Cancer Research Year: 2015 Vol: 4 (1)Pages: 97-106
JOURNAL ARTICLE
Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy
Journal: Clinical Cancer Drugs Year: 2016 Vol: 3 (1)Pages: 36-62
JOURNAL ARTICLE
2 Agents Targeting the mTOR-PI3K-Akt Pathway
Josep TaberneroR. DienstmannTeresa MacarullaCarlos A. SauraGuillem ArgilésMaría AlsinaCarolina Uribe CruzIrene BrañaJavier CortésJordi Rodón
Journal: European Journal of Cancer Year: 2012 Vol: 48 Pages: 3-3